A pilot study investigating the safety and feasibility of embolising the left gastric artery to aid rapid weight-loss in morbidly obese patients awaiting elective surgery.

I-MED Radiology Network0 sites1 target enrollmentFebruary 1, 2021

Overview

No summary available.

Registry

who.int

Start Date

February 1, 2021

End Date

January 28, 2022

Last Updated

last year

Study Type

Interventional

Sex

All

Sponsor

I-MED Radiology Network

•BMI over 35 and weight \<200 kg awaiting elective surgery, non\-bariatric operative candidates; adequate renal, hepatic and haematologic function; able to undergo an angiographic procedure; medically fit enough to undertake mild or moderate exercise, motivated to lose weight and adhere to prescribed dietary advice. Further, patients must have private health insurance to be included in this trial.; BMI over 35 and weight \<200 kg awaiting elective surgery, non\-bariatric operative candidates; adequate renal, hepatic and haematologic function; able to undergo an angiographic procedure; medically fit enough to undertake mild or moderate exercise, motivated to lose weight and adhere to prescribed dietary advice. Further, patients must have private health insurance to be included in this trial.

•Malignancy; pregnancy; active H. pylori infection; autoimmune disease; history of inflammatory bowel disease; eGFR \<35; allergy to intravenous contrast; severe cardiopulmonary dysfunction; serious mental health or mood modulating medication; previous oesophageal or gastric surgery; planned or interest in future bariatric surgery.; Malignancy; pregnancy; active H. pylori infection; autoimmune disease; history of inflammatory bowel disease; eGFR \<35; allergy to intravenous contrast; severe cardiopulmonary dysfunction; serious mental health or mood modulating medication; previous oesophageal or gastric surgery; planned or interest in future bariatric surgery.